Hypoxia-Triggered Singlet Oxygen and Nitrogen Mustard Release Towards a Synergistic Therapeutic Action

Abstract

We report an endoperoxide and nitrogen mustard conjugate (Pyd-endo) as a prodrug which can release cytotoxic singlet oxygen and aromatic nitrogen mustard under hypoxic conditions. Cell culture experiments demonstrated the hypoxia-responsiveness of prodrug and its ability to kill and inhibit the migration and proliferation of various types of cancer cells. Studies using tumor-bearing mice also and a liposomal formulation demonstrated its anticancer utility in vivo. Our design, not only addresses the challenges of tumor hypoxia and limited light penetration issues of PDT, but also present the power of combined cytotoxic action of singlet oxygen and a chemotherapy agent

Supplementary files

Article information

Article type
Communication
Submitted
21 Jan 2025
Accepted
14 Apr 2025
First published
28 Apr 2025

Chem. Commun., 2025, Accepted Manuscript

Hypoxia-Triggered Singlet Oxygen and Nitrogen Mustard Release Towards a Synergistic Therapeutic Action

Y. Qiao, Y. nie, Y. Si, X. Qian, Y. Wu, T. Zhang, B. Liu, L. Wang, E. Akkaya and Z. Chen, Chem. Commun., 2025, Accepted Manuscript , DOI: 10.1039/D5CC00390C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements